Palvella Therapeutics PVLA Q1 2026 Results Fall Short EPS 120 Revenue NA Inszone Expands Into Florida Market With Coastal Optimal Acquisition Outlook Therapeutics OTLK Q1 2026 Results Miss Estimates EPS 016 vs 012 Golub GBDC Q1 2026 Earnings Miss EPS 018 vs 037 Expected WORK Medical Technology WOK Experiences Continued Decline Falls 541 to 010 Yatra Online YTRA Surges 6 as Buying Momentum Builds Near Key Support Leidos Holdings LDOS Rises 181 as Defense Technology Demand Supports Gains CRISPR Therapeutics CRSP Edges Higher as GeneEditing Sector Regains Traction